@Tamaruler
Sorry, no payment if no FDA approval. Deal starts after FDA approval for the take or pay minimum qty. Here is the text:
" Once relevant regulatory authorisations or approvals are obtained..."
+
"Access Bio is obliged to sell a minimum of two million Products by 30 September 2021. If this threshold is not achieved by Access Bio within the timeframe, Access Bio is obliged to make a payment for that number of units short of two million and Access Bio's exclusive rights under the agreement in the United States, Canada and Mexico automatically become non-exclusive."
+
At1 supplies Galileo devices for free for a "...a percentage of the gross revenue from all sales..." for those 2m/yr minimum -devices.
If Access Bio make the threshold, then the deal renews, same conditions for 12mths more and so on (until they re-negotiate anything I guess for higher quantities/different sharing %).
- Forums
- ASX - By Stock
- AT1
- Ann: Atomo receives TGA approval for COVID19 antibody test
Ann: Atomo receives TGA approval for COVID19 antibody test, page-115
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.001(4.00%) |
Mkt cap ! $16.61M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.6¢ | $200 | 7.705K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 42295 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 22000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1091 | 0.027 |
1 | 42295 | 0.026 |
7 | 745137 | 0.025 |
5 | 940383 | 0.024 |
4 | 1110391 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 22000 | 1 |
0.028 | 496971 | 4 |
0.029 | 323106 | 5 |
0.030 | 409488 | 6 |
0.031 | 196496 | 4 |
Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |